Lenzing's August Verdict: A €300m Test of Shareholder Faith
Published on 08/06/2026 at 17:03 | Redaktion boerse-global.de
The arithmetic of Lenzing's turnaround is deceptively simple on paper: net profit doubled to €35.6 million in the first half of 2026, yet revenue slipped to €1.27 billion from €1.34 billion a year earlier. The market's response, however, has been anything but straightforward. After initially shedding 4.45 percent to close at €23.60 on Wednesday, the shares have since clawed back ground, trading at €24.15 on Thursday with a gain of 2.33 percent — a two-day whipsaw that captures the uncertainty surrounding the Austrian fibre maker's most consequential gambit in years.
A portfolio reset with a human cost
The profit improvement is no accident. Lenzing has been deliberately shedding low-margin standard fibres, a strategy formalised under the banner "Grow Nonwovens, Reset Textiles." The revenue decline is the price of that discipline, not evidence of weakening demand. But the transformation carries a heavy toll: production at the Heiligenkreuz site in Austria is slated to close by the end of 2026, followed by the Grimsby facility in the UK by the end of 2027. Roughly 2,000 jobs worldwide are expected to disappear, and the company has flagged non-cash impairments on fixed assets of up to €150 million this fiscal year. The disposal process for the Indonesian viscose operation PT South Pacific Viscose continues in parallel.
The first-quarter numbers had already hinted at the improving trajectory — a positive net result and free cash flow of €45.8 million — and the second quarter extended that run. Georg Kasperkovitz, who took the helm as chief executive in June, now has a clear mandate to execute the overhaul.
The €300m question
All of this restructuring requires capital, and that is where the tension lies. Lenzing has launched a fully guaranteed rights issue of up to €300 million, with the stated aim of strengthening its balance sheet structure over the long term. The anchor shareholders have lined up with unusual solidarity: B&C Gruppe and Suzano S.A. have irrevocably committed to participate pro-rata through a syndicate, contributing approximately €156.7 million combined, while Oberbank has pledged up to €11.6 million. New credit facilities of up to €300 million and an extension of existing liabilities through 2030 round out the financing package — a signal that the lenders, too, are buying into the medium-term targets.
For UK businesses, restructuring of this scale brings its own compliance pressures — and when headcounts and operations shift, workplace safety documentation often falls by the wayside. That gap can prove costly in the event of an incident. A free toolkit with 41 ready-to-use templates and checklists helps you document risks properly and keep your team protected through periods of change. Download the free Risk Assessment Toolkit
Those targets are demanding: an EBITDA improvement of around €150 million, an EBITDA margin between 20 and 25 percent, and leverage below 2.5 times EBITDA. The company's half-year EBITDA of €239.2 million shows progress, but the gap to the stated margin range remains substantial.
A market hedging its bets
The scepticism is understandable. A rights issue of this size will dilute existing holdings, and the success of the placement is not assured until the extraordinary general meeting on 25 August approves it and the remaining shares find buyers outside the core shareholder circle. The stock's behaviour reflects that nervousness: annualised volatility stands at nearly 47 percent, and the shares remain 18.82 percent below their 52-week high of €29.75, reached in June. Against the 200-day moving average, the stock trails by 1.85 percent.
The closures in Heiligenkreuz and Grimsby are announced but not yet executed — schedules can slip, and the reduction of roughly 2,000 positions carries operational and reputational risks. Meanwhile, the shrinking top line, however intentional, narrows the base upon which future growth must be built.
The calendar becomes the catalyst
The next concrete waypoint is 25 August, when shareholders vote not only on the capital increase but also on supervisory board elections. If the core shareholders deliver as promised and the market absorbs the remainder, Lenzing gains the financial runway to execute its plan. If the vote falters or the placement falls well short of the €300 million target, the market will likely reassess the balance sheet risks and punish the stock accordingly.
The third-quarter report, scheduled for 5 November, will provide the next substantive read on whether the operational improvements are holding. For now, Lenzing stands as a test case of whether a European fibre producer can reinvent itself through painful retrenchment — and whether its owners are willing to fund the transition. The answer begins to take shape in less than two weeks.
